Logo image of 1SHL.MI

SIEMENS HEALTHINEERS AG (1SHL.MI) Stock Fundamental Analysis

Europe - BIT:1SHL - DE000SHL1006 - Common Stock

45.67 EUR
-1.93 (-4.05%)
Last: 9/29/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to 1SHL. 1SHL was compared to 63 industry peers in the Health Care Equipment & Supplies industry. While 1SHL is still in line with the averages on profitability rating, there are concerns on its financial health. 1SHL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year 1SHL was profitable.
In the past year 1SHL had a positive cash flow from operations.
Each year in the past 5 years 1SHL has been profitable.
1SHL had a positive operating cash flow in each of the past 5 years.
1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCF1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

1SHL has a Return On Assets of 4.87%. This is in the better half of the industry: 1SHL outperforms 65.57% of its industry peers.
The Return On Equity of 1SHL (12.29%) is better than 75.41% of its industry peers.
1SHL's Return On Invested Capital of 7.89% is fine compared to the rest of the industry. 1SHL outperforms 70.49% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1SHL is below the industry average of 9.52%.
The last Return On Invested Capital (7.89%) for 1SHL is above the 3 year average (5.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.87%
ROE 12.29%
ROIC 7.89%
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1SHL.MI Yearly ROA, ROE, ROIC1SHL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

1SHL has a better Profit Margin (9.29%) than 67.21% of its industry peers.
1SHL's Profit Margin has declined in the last couple of years.
1SHL has a better Operating Margin (13.76%) than 63.93% of its industry peers.
1SHL's Operating Margin has declined in the last couple of years.
1SHL has a Gross Margin of 38.76%. This is in the lower half of the industry: 1SHL underperforms 73.77% of its industry peers.
1SHL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.76%
PM (TTM) 9.29%
GM 38.76%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
1SHL.MI Yearly Profit, Operating, Gross Margins1SHL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1SHL is creating some value.
The number of shares outstanding for 1SHL has been increased compared to 1 year ago.
1SHL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 1SHL has been reduced compared to a year ago.
1SHL.MI Yearly Shares Outstanding1SHL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1SHL.MI Yearly Total Debt VS Total Assets1SHL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

1SHL has an Altman-Z score of 2.04. This is not the best score and indicates that 1SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
1SHL has a Altman-Z score (2.04) which is comparable to the rest of the industry.
The Debt to FCF ratio of 1SHL is 5.10, which is a neutral value as it means it would take 1SHL, 5.10 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1SHL (5.10) is comparable to the rest of the industry.
1SHL has a Debt/Equity ratio of 0.66. This is a neutral value indicating 1SHL is somewhat dependend on debt financing.
The Debt to Equity ratio of 1SHL (0.66) is worse than 68.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.1
Altman-Z 2.04
ROIC/WACC1.28
WACC6.17%
1SHL.MI Yearly LT Debt VS Equity VS FCF1SHL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

1SHL has a Current Ratio of 1.12. This is a normal value and indicates that 1SHL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.12, 1SHL is not doing good in the industry: 67.21% of the companies in the same industry are doing better.
1SHL has a Quick Ratio of 1.12. This is a bad value and indicates that 1SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
1SHL has a Quick ratio of 0.77. This is in the lower half of the industry: 1SHL underperforms 67.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.77
1SHL.MI Yearly Current Assets VS Current Liabilites1SHL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.21% over the past year.
The Earnings Per Share has been growing slightly by 7.27% on average over the past years.
The Revenue has been growing slightly by 5.85% in the past year.
Measured over the past years, 1SHL shows a quite strong growth in Revenue. The Revenue has been growing by 9.02% on average per year.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%

3.2 Future

The Earnings Per Share is expected to grow by 9.71% on average over the next years. This is quite good.
Based on estimates for the next years, 1SHL will show a small growth in Revenue. The Revenue will grow by 5.62% on average per year.
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1SHL.MI Yearly Revenue VS Estimates1SHL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
1SHL.MI Yearly EPS VS Estimates1SHL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.19, which indicates a rather expensive current valuation of 1SHL.
83.61% of the companies in the same industry are more expensive than 1SHL, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.50. 1SHL is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 17.47 indicates a rather expensive valuation of 1SHL.
Based on the Price/Forward Earnings ratio, 1SHL is valued a bit cheaper than 72.13% of the companies in the same industry.
1SHL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.19
Fwd PE 17.47
1SHL.MI Price Earnings VS Forward Price Earnings1SHL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

65.57% of the companies in the same industry are more expensive than 1SHL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, 1SHL is valued cheaper than 88.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.75
EV/EBITDA 14.19
1SHL.MI Per share data1SHL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of 1SHL may justify a higher PE ratio.
PEG (NY)1.98
PEG (5Y)2.64
EPS Next 2Y8.26%
EPS Next 3Y9.53%

6

5. Dividend

5.1 Amount

1SHL has a Yearly Dividend Yield of 1.96%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.09, 1SHL pays a better dividend. On top of this 1SHL pays more dividend than 80.33% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, 1SHL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.96%

5.2 History

On average, the dividend of 1SHL grows each year by 6.35%, which is quite nice.
Dividend Growth(5Y)6.35%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

49.08% of the earnings are spent on dividend by 1SHL. This is a bit on the high side, but may be sustainable.
1SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.08%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
1SHL.MI Yearly Income VS Free CF VS Dividend1SHL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
1SHL.MI Dividend Payout.1SHL.MI Dividend Payout, showing the Payout Ratio.1SHL.MI Dividend Payout.PayoutRetained Earnings

SIEMENS HEALTHINEERS AG

BIT:1SHL (9/29/2025, 7:00:00 PM)

45.67

-1.93 (-4.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-30 2025-07-30/dmh
Earnings (Next)11-05 2025-11-05/amc
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap51.52B
Analysts83.7
Price Target61.96 (35.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.96%
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP49.08%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.66%
Min EPS beat(2)-2.04%
Max EPS beat(2)13.36%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-2.04%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)3.25%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)2.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)0.36%
PT rev (3m)-0.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.03%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-2.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.82%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.76%
Valuation
Industry RankSector Rank
PE 19.19
Fwd PE 17.47
P/S 2.2
P/FCF 16.75
P/OCF 13.39
P/B 2.91
P/tB N/A
EV/EBITDA 14.19
EPS(TTM)2.38
EY5.21%
EPS(NY)2.61
Fwd EY5.72%
FCF(TTM)2.73
FCFY5.97%
OCF(TTM)3.41
OCFY7.47%
SpS20.73
BVpS15.67
TBVpS-5.42
PEG (NY)1.98
PEG (5Y)2.64
Profitability
Industry RankSector Rank
ROA 4.87%
ROE 12.29%
ROCE 10.07%
ROIC 7.89%
ROICexc 8.64%
ROICexgc 46.76%
OM 13.76%
PM (TTM) 9.29%
GM 38.76%
FCFM 13.16%
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexcg growth 3Y-8.79%
ROICexcg growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.1
Debt/EBITDA 2.58
Cap/Depr 59.37%
Cap/Sales 3.29%
Interest Coverage 7.09
Cash Conversion 85.2%
Profit Quality 141.62%
Current Ratio 1.12
Quick Ratio 0.77
Altman-Z 2.04
F-Score8
WACC6.17%
ROIC/WACC1.28
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%
EBIT growth 1Y18.19%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.21%
EBIT Next 3Y20.47%
EBIT Next 5Y15.42%
FCF growth 1Y161.12%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y86.79%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%